Share this Post!


This Circular aims to:

  1. Establish the guidelines for the licensing and inspection of HUHS establishments;
  2. Establish the guidelines for registration and other relevant authorizations for HUHS products;
  3. Update the categorization of HUHS products;
  4. Institutionalize the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) as the new hazard category for labeling of HUHS products; and
  5. Ensure compliance of HUHS establishments to FDA regulatory standards, such as but not limited to Good Manufacturing Practice (GSP); or Good Distribution Practice (GDP), or Good Storage Practice (GSP); or Good Labeling Practice (GLP).

Read more:->FDA Circular No.2020-025